A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
S Di MolfettaP PatrunoS CormioA CignarelliR PaleariA MoscaO LamacchiaS De CosmoM MassaA NatalicchioS PerriniL LaviolaFrancesco GiorginoPublished in: Journal of endocrinological investigation (2022)
The use of the Glucoonline™ system resulted in improved metabolic control. Telemedicine services have potential to support diabetes self-management and provide the patients with remote, prompt assistance using affordable technological equipment. Trial registration This study was registered at clinicaltrials.gov (NCT01804803) on March 5, 2013.
Keyphrases
- glycemic control
- blood glucose
- type diabetes
- cardiovascular disease
- weight loss
- healthcare
- insulin resistance
- primary care
- clinical trial
- electronic health record
- mental health
- phase iii
- machine learning
- phase ii
- metabolic syndrome
- randomized controlled trial
- risk assessment
- skeletal muscle
- adipose tissue
- deep learning